Sponsored Content by LonzaReviewed by Ify IsiborMay 1 2026In the early 2000s, scientists were focused on discovery: a new protein, a new story. What scientists couldn’t have known at the time was that the very instruments they were fine-tuning for basic science – including mass spectrometers – would become essential to the biomanufacturing of life-saving biological drugs. In the modern day, mass spectrometry is a foundation of chemistry, manufacturing, and controls (CMC) development for biologics. It is especially valued for its accuracy, versatility, and depth. As Head of Omics & Informatics at Lonza, Sabrina Liberatori has witnessed advancements in pharma...